wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33422258-1A66848E-62BC-4AD4-B048-57518C0F7A40
Q33422258-1A66848E-62BC-4AD4-B048-57518C0F7A40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-1A66848E-62BC-4AD4-B048-57518C0F7A40
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.
P2860
Q33422258-1A66848E-62BC-4AD4-B048-57518C0F7A40
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33422258-1A66848E-62BC-4AD4-B048-57518C0F7A40
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27b269ef3ab22a069302766eacd99fb1ffaa42c5
P2860
Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.